Now Accepting Public Comments through June 8, 2026 on the Draft 2027 CMS QRDA III Implementation Guide, Schematron, and Sample File for Eligible Clinicians
Top
Official websites use
.gov
A .gov website belongs to an official government organization in the United States.
Secure
.gov
websites use HTTPS
A
lock
(
)
or
https://
means you’ve safely connected to the
.gov
website. Share sensitive information only on official, secure websites.
["Route": "Subcutaneous Route"]
Performance/Reporting Period
2024
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for a medication administered by subcutaneous route.
Data Element Scope: This value set may use a model element related to Medication.
Inclusion Criteria: Includes concepts that identify a medication given subcutaneously.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use a model element related to Medication.
Inclusion Criteria: Includes concepts that identify a medication given subcutaneously.
Exclusion Criteria: No exclusions.
Constrained to codes in the Subcutaneous route value set (2.16.840.1.113883.3.117.1.7.1.223)
QDM Datatype and Definition
route
Refers to the path by which the medication or substance should be taken into the body system, such as intradermally, intrathecally, intramuscularly, intranasally, intravenously, orally, rectally, subcutaneously, sublingually, topically, or vaginally.
eCQMs using this data element:
Last Updated: Jun 29, 2023